Barclays »

Haemonetics Corp Mass shares owned by Barclays

Quarter-by-quarter ownership of Haemonetics Corp Mass shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Haemonetics Corp Mass

Tip: Access up to 7 years of quarterly data

All positions including Haemonetics Corp Mass held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Haemonetics Corp Mass by Barclays

Quarter filed Position value Share count Share price at filing
2025-12-31 $370k 356k 1.04

More positions owned by Barclays

SPDR S&ampP 500 ETF TR Fund (SPY)
Invesco Qqq Tr Fund (QQQ)
NVIDIA Corporation (NVDA)
Microsoft Corp Opt Put Option (MSFT)
Apple (AAPL)
Ishares Tr Opt Call Option (IWM)
Alphabet Inc Class A cs (GOOGL)
Amazon (AMZN)
Tesla Motors (TSLA)
Facebook Inc cl a (META)
Broadcom (AVGO)
Alphabet Inc Class C cs (GOOG)
Ishares Tr Opt Put Option (HYG)
Advanced Micro Devices (AMD)
JPMORGAN CHASE &amp Opt Put Option (JPM)

View all positions for Barclays

Top funds holding Haemonetics Corp Mass

Linden Advisors
Wolverine Asset Management
BlackRock
Invesco
Franklin Resources
Zazove Associates
Wellesley Investment Advisors
Context Capital Management
Advent Capital Management
State Street Corporation
CSS
Calamos Advisors
Lazard Asset Management
Wells Fargo & Company
Silverback Asset Management

View all funds holding Haemonetics Corp Mass